COURSE PRESIDENT

Sandro Barni

Emeritus Director of Oncology Department, ASST-BGOVEST, Ospedale di Treviglio Bergamo, (Italy).

SCIENTIFIC COMMITTEE

Sandro Barni

Emeritus Director of Oncology Department, ASST-BGOVEST, Ospedale di Treviglio Bergamo, (Italy).

Manuel Muñoz

Department of Surgical Specialties, Biochemistry and Immunology, University of Málaga, (Spain).

Member of NATA’s Board of Directors (Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis).

Germano Tarantino

Chief Scientific Officier Pharmanutra SpA, Pisa (Italy).

FRIDAY, MARCH 8th

  • 14:00

    WELCOME ADDRESS AND COURSE INTRODUCTION

    Sandro Barni

    Manuel Muñoz

    Germano Tarantino

  • 14:10

    MAGISTERIAL LECTURE

    IRON: THE PRECIOUS METAL OF LIFE

    Speaker: Professor (Emeritus) Ioav Cabantchik

    President IBIS: International Bioiron Society

    International Society for the Study of Iron in Biology and Medicine

    Institute of Life Sciences, Hebrew University Jerusalem, (Israel)

  • 14.40-15.25

    First Session
    Patient Blood Management in Obstetric and Pedriatrics: First Pillar

    Chair: Manuel Muñoz

  • 14:40

    patient blood management in pedriatric surgery 

    Speaker: Aryeh Shander

    Department of Anaesthesiology, Critical Care and Hyperbaric Medicine, Englewood Hospital and Medical Centre, Englewood, New Jersey, (USA)

  • 15.00

    MULTIDISCIPLINARY PROTOCOL FOR IRON DEFICIENCY ANEMIA MANAGEMENT IN PRE-PARTUM. FIRST YEAR APPLICATION UPDATE

    Speaker: Maria Beatrice Rondinelli

    Department of Transfusion Medicine, San Camillo-Forlanini Hospital, Rome (Italy)

  • 15.15

    Session discussion

  • 15.25-16.30

    second SESSION – Iron deficiency and iron supplementation in Neonatology and Pediatrics

    Chair: Dámaso Infante Pina
    Jefe de Servicio Gastroenterología y Nutrición Pedriatric Hospital Universitario General de Cataluña, Barcelona (Spain)

  • 15:25

    IRON DEFICIENCY IN NEONATOLOGY AND PEDIATRICS: STATE OF THE ART

    Speaker: Claudio Cerchione

    Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

  • 15:40

    EFFICACY OF IRON PROPHYLAXIS FOR PREVENTION OF IRON DEFICIENCY IN PRETERM BABIES

    Speaker: Enrico Gasparrini

    Neonatolgy and Neonatal follow-up Unit, Hospital of Macerata, Italy

  • 15:55

    A CHILD WITH SEVERE IRON-DEFICIENCY ANEMIA AND A COMPLEX TMPRSS6 GENOTYPE (IRIDA)

    Speaker: Laura Cannavò

    University Hospital of Messina, Messina, Italy

  • 16:10

    SESSION DISCUSSION

  • 16:20

    COFFEE BREAK

  • 16:20 - 16:50

    POSTER SESSION

  • 16.50-17.50

    THIRD SESSION – Iron deficiency and iron supplementation in Obstetrics and Gynaecology

    Chair: Manuel Muñoz

  • 16:50

    MANAGEMENT OF IRON DEFICIENCY IN HIGH RISK PREGNANT WOMEN IN ISRAEL – OUR EXPERIENCE WITH BEDOUIN POPULATION

    Speaker: Ehud Raz

    Obstetrics and Gynecologist specialist, Omer (Israel)

  • 17:05

    EFFICACY OF ORAL SUCROSOMIAL® IRON IN PUERPERIUM ANEMIA

    Speaker: : Stefano Berardi
    Department of Obstetrics and Gynecology, Ca’ Foncello Hospital, Treviso (Italy)

  • 17:20

    IRON DEFICIENCY ANEMIA IN GYNECOLOGY, FOCUS ON GYNECOLOGIC ONCOLOGY

    Speaker: Claudia Marchetti

    Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Rome (Italy)

  • 17:35

    SESSION DISCUSSION

  • 17:50 - 19:00

    FOURTH SESSION

    Sucrosomial Iron®: Mechanism of Action  and Pre-clinical Evidences

    Chair: Paolo Arosio

     Department of Molecular and Translational Medicine, University of Brescia, Italy

  • 17:50

    RECENT NEW EVIDENCES ON SUCROSOMIAL® IRON: STATE OF ART

    Speaker: Germano Tarantino

    Chief Scientific Officer Pharmanutra Spa, Pisa (Italy)

  • 18:05

    STUDY OF M CELLS ROLE IN SUCROSOMIAL® IRON ABSORPTION PATHWAY

    Speaker:  Ramon Barnadas Rodriguez*

    Autonomous University of Barcelona, UAB (Spain)

    and  Mercedes Camacho Perez

    San Pau Hospital, Barcelona (Spain)

  • 18:20

    SUCROSOMIAL® IRON SUPPLEMENTATION IN MICE: EFFECTS ON BLOOD PARAMETERS, HEPCIDIN AND INFLAMMATION

    Speaker: Maura Poli

    Department of Molecular and Translational Medicine, University of Brescia, (Italy)

  • 18:35

    ORAL SUCROSOMIAL® IRON COMPARED TO TRADITIONAL PARENTERAL IRON DEXTRAN SUPPLEMENTATION IN PIGLETS: ABSORPTION, TISSUES DISTRIBUTION AND OXIDATIVE STRESS

    Speaker: Pawel Lipinski

    Institute of Genetics and Animal Breeding Polish Academy of Sciences, Jastrzębiec, (Poland)

  • 18:50

    Session Discussion

  • 19-00

    Closure First Day, 7th IMCID 2019

SATURDAY, MARCH 9th

  • 7th IMCID Second Day Opening

  • 08:45

    UP-TO-DATE REVIEW OF PUBLISHED CLINICAL RESEARCH ON SUCROSOMIAL® IRON

    Speakers: Manuel Muñoz

  • 09:10 -10:05

    FifTH SESSION – Experience with Sucrosomial® Iron in Inflammatory Bowel Disease 

    Chair: Guillermo Bastida

    Department of Digestive Diseases. Politècnic University Hospital La Fe, Valencia (Spain)

  • 09:10

    SUCROSOMIAL® IRON VS INTRAVENOUS IRON: RESULTS OF A COMPARATIVE STUDY IN IBD PATIENTS WITH ANEMIA

    Speaker: Nikolai Stuklov

    RUDN University, National Medical Research Center of Radiology, Moscow (Russia)

  • 09:25

    SAFETY AND EFFICACY OF SUCROSOMIAL® IRON IN IRON-DEFICIENT ANEMIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

    Speaker: Gianluca Abbati

    Department of Medicine University Hospital of Modena, Modena (Italy)

  • 09:40

    PHARMACOECONOMIC BENEFITS OF SUCROSOMIAL® VS INTRAVENOUS IRON IN IBD PATIENTS WITH IRON DEFICIENCY ANEMIA

    Speaker: Meritxell Ascanio
    Senior Consultant BCN Health Economics & Outcomes Research, Barcelona (Spain)

  • 09:55

    Session Discussion

  • 10:05- 10:40

    SixTH SESSION – Nephrology experience

    Chair: Antonio Pisani

    Chair of Nephrology, Department of Public Health, University Federico II of Naples, (Italy)

  • 10:05

    SUCROSOMIAL® IRON AS MAINTENANCE THERAPY IN CKD ANEMIC PATIENTS

    Speaker: Nada Dimkovic
    Clinical Department for Renal Diseases, Zvezdara University Medical Center, Belgrade (Serbia)

  • 10:20

    ORAL SUCROSOMIAL® IRON VERSUS INTRAVENOUS IRON FOR RECOVERING IRON DEFICIENCY ANAEMIA IN ND-CKD PATIENTS: A COST- MINIMIZATION ANALYSIS

    Speaker: Federica Romano
    Università Cattolica del Sacro Cuore, Rome, Italy

  • 10:35

    Session Discussion

  • 10:40

    COFFEE BREAK

  • 10:40 - 11:10

    POSTER SESSION

  • 11:10-12:20

    SEVENTH SESSION – Oncology and Internal Medicine

    Chair: Sandro Barni

  • 11:10

    POSITION PAPER ON MANAGEMENT OF IRON DEFICIENCY IN ADULT CANCER PATIENTS

    Speaker: Sandro Barni

  • 11.20

    THE IMPACT OF IRON DEFICIENCY ANEMIA ON QUALITY OF LIFE IN CANCER PATIENTS

    Speaker: Emilio Bria

    Medical Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (Italy)

  • 11:35

    RISK OF ANEMIA WITH IMMUNE CHECKPOINT INHIBITORS: A REVIEW OF THE LITERATURE

    Speaker: Raffaele Ardito

    Director of Oncology Day Hospital Unit, IRCCS  CROB, Rionero in Vulture, Potenza (Italy)

  • 11:50

    ORAL HIGH-DOSE SUCROSOMIAL® IRON VS. INTRAVENOUS IRON IN SIDEROPENIC ANEMIA INTOLERANT OR REFRACTORY TO IRON SULFATE

    Speaker: Giulio Giordano
    Regional Hospital A.Cardarelli ASREM, Campobasso, Italy

  • 12:10

    Session Discussion

  • 12:20 - 13:15

    EIGHTH SESSION – Patient Blood Management

    Chair: Manuel Muñoz

  • 12:20

    PBM IN HIP REPLACEMENT

    Speaker: Marco Scardino

    Hip and Prosthetic Orthopedics OU, Humanitas Research Hospital, Rozzano (Italy)

  • 12:35

    PRE-OPERATIVE CARDIO SURGERY PROTOCOL IMPLEMENTATION WITH SUCROSOMIAL® IRON

     Speaker: Luca Weltert

    Cardiosurgery Division, European Hospital, Rome (Italy)

  • 12:50

    Session Discussion

  • 13:00

    MAIN RELEVANT MESSAGES FROM 7TH IMCID, 2019

    Speaker: Manuel Muñoz

  • 13:15

    Closure

    Sandro Barni

    Manuel Muñoz

    Germano Tarantino

  • 13:30

    LUNCH